These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2234654)

  • 1. Doxorubicin-associated hyperpigmentation.
    Curran CF
    N Z Med J; 1990 Oct; 103(900):517. PubMed ID: 2234654
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxorubicin induced hyperpigmentation.
    Kumar L; Kochupillai V
    N Z Med J; 1990 Apr; 103(887):165. PubMed ID: 2342686
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nail hyperpigmentation as a secondary effect of doxorubicin].
    Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez C; Gutiérrez del Río C
    Med Clin (Barc); 1982 Jun; 79(1):49-50. PubMed ID: 7121110
    [No Abstract]   [Full Text] [Related]  

  • 4. Pigmentation with doxorubicin therapy.
    Orr LE; McKernan JF
    Arch Dermatol; 1980 Mar; 116(3):273. PubMed ID: 6245620
    [No Abstract]   [Full Text] [Related]  

  • 5. Doxorubicin and hyperpigmentation.
    Alagaratnam TT; Choi TK; Ong GB
    Aust N Z J Surg; 1982 Oct; 52(5):531-3. PubMed ID: 6959604
    [No Abstract]   [Full Text] [Related]  

  • 6. Nail hyperpigmentation secondary to therapy with doxorubicin.
    Giacobetti R; Esterly NB; Morgan ER
    Am J Dis Child; 1981 Apr; 135(4):317-8. PubMed ID: 7211789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nail pigmentation during therapy with cyclophosphamide and doxorubicin].
    Manigand G; Faux N; Dumas D; Taillandier J; Fixy P; Richerd F
    Sem Hop; 1983 Jun; 59(24):1840-1. PubMed ID: 6136095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation.
    Kew MC; Mzamane D; Smith AG; Shuster S
    Lancet; 1977 Apr; 1(8015):811. PubMed ID: 66615
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Hyperpigmentation of nails from doxorubicin.
    Pratt CB; Shanks EC
    JAMA; 1974 Apr; 228(4):460. PubMed ID: 4406195
    [No Abstract]   [Full Text] [Related]  

  • 10. Blue-gray pigmentation in a patient receiving doxorubicin.
    Konohana A
    J Dermatol; 1992 Apr; 19(4):250-2. PubMed ID: 1318885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Adriamycin and longitudinal pigmented banding of fingernails.
    Priestman TJ; James KW
    Lancet; 1975 Jun; 1(7920):1337-8. PubMed ID: 49535
    [No Abstract]   [Full Text] [Related]  

  • 12. Horizontal pigmented banding of the nails in association with adriamycin chemotherapy.
    Morris D; Aisner J; Wiernik PH
    Cancer Treat Rep; 1977; 61(3):499-501. PubMed ID: 872150
    [No Abstract]   [Full Text] [Related]  

  • 13. Minocycline-induced hyperpigmentation.
    Hung PH; Caldwell JB; James WD
    J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
    Paulides M; Kremers A; Stöhr W; Bielack S; Jürgens H; Treuner J; Beck JD; Langer T;
    Pediatr Blood Cancer; 2006 Apr; 46(4):489-95. PubMed ID: 16333817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib-associated hyperpigmentation, a side effect that should be recognized.
    Mcpherson T; Sherman V; Turner R
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):82-3. PubMed ID: 18384557
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperpigmentation and zidovudine].
    Valencia ME; López Duplá JM; Lavilla P; Gil Aguado A
    Med Clin (Barc); 1989 Mar; 92(9):357-8. PubMed ID: 2716434
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperpigmentation with daunorubicin therapy.
    Kelly TM; Fishman LM; Lessner HE
    Arch Dermatol; 1984 Feb; 120(2):262-3. PubMed ID: 6696484
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperpigmentation due to ovulation inhibitors].
    Braun-Falco EO
    Dtsch Med Wochenschr; 1972 Jan; 97(2):57-8. PubMed ID: 5008206
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cutaneous hyperpigmentation and vidarabine].
    Cirera L; Palou J; Estapé J
    Med Clin (Barc); 1983 Nov; 81(15):693. PubMed ID: 6656419
    [No Abstract]   [Full Text] [Related]  

  • 20. Azidothymidine-induced hyperpigmentation of skin and nails.
    Bendick C; Rasokat H; Steigleder GK
    Arch Dermatol; 1989 Sep; 125(9):1285-6. PubMed ID: 2774609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.